Darling Ingredients (NYSE: DAR) plans 2026 sale of award shares
Rhea-AI Filing Summary
Darling Ingredients Inc. filed a notice of proposed sales of common stock under Form 144. The planned sales are to be effected through Citigroup Global Markets on or after 08/17/2026 on the NYSE. The shares relate to a stock option exercise granted in 2019–2021 and an employee stock award granted on 03/07/2023.
Positive
- None.
Negative
- None.
Key Figures
Shares from stock option net exercise: 2,593 shares
Shares from employee stock award: 3,876 shares
Planned sale start date: 08/17/2026
3 metrics
Shares from stock option net exercise
2,593 shares
Common stock tied to stock option net exercise to be sold on or after 08/17/2026
Shares from employee stock award
3,876 shares
Common stock from employee stock award granted on 03/07/2023 referenced in Form 144
Planned sale start date
08/17/2026
Date associated with proposed sales and stock option net exercise transactions
Key Terms
Form 144, Stock Option Net Exercise, Employee Stock Award
3 terms
Form 144 regulatory
"Darling Ingredients Inc. filed a notice of proposed sales of common stock under Form 144"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock Option Net Exercise financial
"2593 | 08/17/2026 | Stock Option Net Exercise Common Stock"
Employee Stock Award financial
"Common Stock | 03/07/2023 | Employee Stock Award | Darling Ingredients Inc."
FAQ
What does Darling Ingredients Inc. (DAR) disclose in this Form 144 filing?
Darling Ingredients Inc. discloses a proposed sale of common stock under Form 144. The shares are tied to a stock option exercise from grants in 2019–2021 and an employee stock award granted on 03/07/2023.
Which broker will handle the proposed Form 144 sales for Darling Ingredients (DAR)?
The proposed Form 144 sales will be handled by Citigroup Global Markets. The broker is identified with its New York address, and the sales are expected to take place on the NYSE after the disclosed date.
When are the proposed Form 144 sales for Darling Ingredients (DAR) scheduled to begin?
The proposed sales are scheduled to begin on or after 08/17/2026. That date appears both in the securities information and in connection with the stock option net exercise, indicating the contemplated timing for the potential disposition.
AI-generated analysis. How Rhea-AI works. Not financial advice.